PEStore

Venture Capital

Flare Capital

Flare Capital backs early-stage and high-growth companies, typically pre-profit, from United States. It states a focus on healthcare & life sciences.

Disclosed holdings43
Earliest stated investment2015
HeadquartersUnited States
Largest single fundNot stated

Regulatory record

How Flare Capital is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised5 · $945m gross
SEC adviser numberCRD 161805

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Flare Capital lists on its own website. 10 carry a stated investment year.

CompanyInvestedYears heldRecorded transaction
Iora Health201511
Aetion20179
Eden Health20206
Author Health20215
Axuall20215
Beaming Health20215
Beme Health20215
Elektra Health20215
Birchai20224
Bonsai Health20251
Adni
Alden
BridgeHealthAI
Budgie Health
Cerula Care
Chiyo
Core
Core Matthew Murphy Co-Founder CEO
Darby
Eternal
Ethicos Health
Frame
Greatly Health
Healink
Helm
Inner Logic
Jaide Health
Kairon Health
Laptis
Marigold Health
Narrable
OncoveryCare
Pear Suite
Percipio
Piction Health
Qualified Health
Rosarium Health
Sprouts Labs
TandemStride
Vincere Health
Visana Health
Vivo
Zeal AI

Compiled from Flare Capital’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Flare Capital?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.